The U.S. spends lavishly on healthcare yet can’t answer basic questions about Covid-19. Some of the best research has come from Israel. American public health agencies should be producing data on breakthrough infections, boosters and natural immunity. But the Centers for Disease Control and Prevention has failed to provide the information needed to inform a sound Covid strategy.
Israel began its vaccine rollout with Pfizer in December, only days after the U.S. But Israel kept good data, reported them out frequently and quickly, and used them to track subsequent Covid infections. When the White House announced its plan to recommend a booster shot for all Americans, it cited Israeli data. The World Health Organization and others criticized the plan, calling the evidence insufficient, and in what seemed like a coordinated protest, two top scientists at the Food and Drug Administration abruptly resigned.
